Literature DB >> 4006868

Rapid and selective inner ring deiodination of thyroxine sulfate by rat liver deiodinase.

J A Mol, T J Visser.   

Abstract

Previous studies have shown that the inner ring deiodination (IRD) of T3 and the outer ring deiodination (ORD) of 3,3'-diiodothyronine are greatly enhanced by sulfate conjugation. This study was undertaken to evaluate the effect of sulfation on T4 and rT3 deiodination. Iodothyronine sulfate conjugates were chemically synthetized. Deiodination was studied by reaction of rat liver microsomes with unlabeled or outer ring 125I-labeled sulfate conjugate at 37 C and pH 7.2 in the presence of 5 mM dithiothreitol. Products were analyzed by HPLC or after hydrolysis by specific RIAs. T4 sulfate (T4S) was rapidly degraded by IRD to rT3S, with an apparent Km of 0.3 microM and a maximum velocity (Vmax) of 530 pmol/min X mg protein. The Vmax to Km ratio of T4S IRD was increased 200-fold compared with that of T4 IRD. However, formation of T3S by ORD of T4S could not be observed. The rT3S formed was rapidly converted by ORD to 3,3'-T2 sulfate, with an apparent Km of 0.06 microM and a Vmax of 516 pmol/min X mg protein. The enzymic mechanism of the IRD of T4S was the same as that of the deiodination of nonsulfated iodothyronines, as shown by the kinetics of stimulation by dithiothreitol or inhibition by propylthiouracil. The IRD of T4S and the ORD of rT3 were equally affected by a number of competitive inhibitors, suggesting a single enzyme for the deiodination of native and sulfated iodothyronines. In conjunction with previous findings on the deiodination of T3S, these results suggest that sulfation leads to a rapid and irreversible inactivation of thyroid hormone.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4006868     DOI: 10.1210/endo-117-1-8

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  13 in total

1.  Effects of substitution and high-dose thyroid hormone therapy on deiodination, sulfoconjugation, and tissue thyroid hormone levels in prolonged critically ill rabbits.

Authors:  Yves Debaveye; Björn Ellger; Liese Mebis; Theo J Visser; Veerle M Darras; Greet Van den Berghe
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

2.  Type 2 iodothyronine deiodinase is highly expressed in human thyroid.

Authors:  D Salvatore; H Tu; J W Harney; P R Larsen
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

3.  Regulation of constitutive androstane receptor and its target genes by fasting, cAMP, hepatocyte nuclear factor alpha, and the coactivator peroxisome proliferator-activated receptor gamma coactivator-1alpha.

Authors:  Xunshan Ding; Kristin Lichti; Insook Kim; Frank J Gonzalez; Jeff L Staudinger
Journal:  J Biol Chem       Date:  2006-07-05       Impact factor: 5.157

4.  NPY and MC4R signaling regulate thyroid hormone levels during fasting through both central and peripheral pathways.

Authors:  Kristen R Vella; Preeti Ramadoss; Francis S Lam; Jamie C Harris; Felix D Ye; Paul D Same; Nicholas F O'Neill; Eleftheria Maratos-Flier; Anthony N Hollenberg
Journal:  Cell Metab       Date:  2011-11-17       Impact factor: 27.287

5.  Alterations in 3,3'5'-triiodothyronine metabolism in response to propylthiouracil, dexamethasone, and thyroxine administration in man.

Authors:  J S LoPresti; A Eigen; E Kaptein; K P Anderson; C A Spencer; J T Nicoloff
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

6.  Metabolism of reverse triiodothyronine by isolated rat hepatocytes.

Authors:  S J Rooda; M A van Loon; T J Visser
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

7.  Intrinsic expression of a multiexon type 3 deiodinase gene controls zebrafish embryo size.

Authors:  Cuicui Guo; Xia Chen; Huaidong Song; Michelle A Maynard; Yi Zhou; Alexei V Lobanov; Vadim N Gladyshev; Jared J Ganis; David Wiley; Rebecca H Jugo; Nicholas Y Lee; Luciana A Castroneves; Leonard I Zon; Thomas S Scanlan; Henry A Feldman; Stephen A Huang
Journal:  Endocrinology       Date:  2014-07-08       Impact factor: 4.736

Review 8.  A Review of the Pharmacokinetics of Levothyroxine for the Treatment of Hypothyroidism.

Authors:  Philippe Colucci; Corinne Seng Yue; Murray Ducharme; Salvatore Benvenga
Journal:  Eur Endocrinol       Date:  2013-03-15

Review 9.  Tissue thyroid hormones and thyronamines.

Authors:  Alice Accorroni; Federica Saponaro; Riccardo Zucchi
Journal:  Heart Fail Rev       Date:  2016-07       Impact factor: 4.214

Review 10.  Neonatal thyroid disorders.

Authors:  A L Ogilvy-Stuart
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-11       Impact factor: 5.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.